Literature DB >> 15206105

Polynuclear platinum drugs.

Nicholas Farrell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15206105

Source DB:  PubMed          Journal:  Met Ions Biol Syst        ISSN： 0161-5149


× No keyword cloud information.
  24 in total

1.  The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.

Authors:  Eva I Montero; Junyong Zhang; Joseph J Moniodis; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2010-08-09       Impact factor: 5.236

2.  Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma.

Authors:  Christine Billecke; Susan Finniss; Laura Tahash; Cathie Miller; Tom Mikkelsen; Nicholas P Farrell; Oliver Bögler
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

3.  Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.

Authors:  Junyong Zhang; Donald S Thomas; Susan J Berners-Price; Nicholas Farrell
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

4.  Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.

Authors:  Ho-Shin Gwak; Takashi Shingu; Vaibhav Chumbalkar; Yeo-Hyeon Hwang; Robert DeJournett; Khatri Latha; Dimpy Koul; W K Alfred Yung; Garth Powis; Nicholas P Farrell; Oliver Bögler
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

5.  Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells.

Authors:  Peyman Kabolizadeh; Brigitte J Engelmann; Nicholas Pullen; Jennifer K Stewart; John J Ryan; Nicholas P Farrell
Journal:  J Biol Inorg Chem       Date:  2011-09-15       Impact factor: 3.358

6.  Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting.

Authors:  Katherine S Lovejoy; Stephen J Lippard
Journal:  Dalton Trans       Date:  2009-10-01       Impact factor: 4.390

7.  [Au2(phen(2Me))2(μ-O)2](PF6)2, a Novel Dinuclear Gold(III) Complex Showing Excellent Antiproliferative Properties.

Authors:  Maria A Cinellu; Laura Maiore; Mario Manassero; Angela Casini; Massimiliano Arca; Heinz-Herbert Fiebig; Gerhard Kelter; Elena Michelucci; Giuseppe Pieraccini; Chiara Gabbiani; Luigi Messori
Journal:  ACS Med Chem Lett       Date:  2010-07-02       Impact factor: 4.345

8.  Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: a comparison with the 5'-5' directional isomer.

Authors:  Rasha A Ruhayel; Joseph J Moniodis; Xiaohong Yang; Jana Kasparkova; Viktor Brabec; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2009-09-21       Impact factor: 5.236

9.  cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.

Authors:  Katherine S Lovejoy; Ryan C Todd; Shuzhong Zhang; Michael S McCormick; J Alejandro D'Aquino; Joyce T Reardon; Aziz Sancar; Kathleen M Giacomini; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

10.  Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

Authors:  Lenka Zerzankova; Tereza Suchankova; Oldrich Vrana; Nicholas P Farrell; Viktor Brabec; Jana Kasparkova
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.